A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint Discomfort

Part of paid clinical trials in Dallas, Texas.

Sponsor
Able Biolabs, LLC
Study ID
NCT07602426
Status
Active Not Recruiting

Conditions

  • Joint Discomfort
  • Mobility Limitation
  • Musculoskeletal Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Placebo — OTHER
    Inactivated supplement
  • Supplement — DIETARY_SUPPLEMENT
    Active supplement

Study Details

This randomized, double-blind, placebo-controlled study evaluates the effects of resO™ Bone and Joint Support Postbiotic on physical function, pain interference, mobility, and recovery in adults aged 18-75 years experiencing joint discomfort, stiffness, or reduced mobility. Participants will be randomized to receive either resO™ or placebo for 4 weeks. Outcomes will be assessed using validated patient-reported outcome measures, including PROMIS Physical Function, PROMIS Pain Interference, Duke Activity Status Index (DASI), International Physical Activity Questionnaire-Short Form (IPAQ-SF), and pain numeric rating scales. The primary objective is to evaluate whether resO™ improves physical function and reduces pain interference compared with placebo.

Key Dates

Start date
Apr 13, 2026
Status verified
May 2026
Primary completion
May 15, 2026
Completion
May 31, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Placebo Comparator: Placebo
  • Experimental: Supplement

Primary Outcome Measure

Change From Baseline to Week 4 in PROMIS Physical Function T-score [ Time Frame: Baseline and Week 4 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Able Biolabs LLCDallasTexas75247-

Find similar trials in Dallas, TX

By research site
Able Biolabs LLC· Dallas, TX

Related Studies